NASDAQ:BLAC Bellevue Life Sciences Acquisition (BLAC) Stock Price, News & Analysis → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free BLAC Stock Alerts $10.76 +0.04 (+0.37%) (As of 05/15/2024 ET) Add Compare Share Share Today's Range$10.73▼$11.0050-Day Range$10.64▼$10.9152-Week Range$10.17▼$11.60Volume5,090 shsAverage Volume38,298 shsMarket Capitalization$60.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Get Bellevue Life Sciences Acquisition alerts: Email Address Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. About Bellevue Life Sciences AcquisitionBellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Read More BLAC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BLAC Stock News HeadlinesMay 13 at 9:05 AM | prnewswire.comBellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder MeetingMay 12, 2024 | americanbankingnews.comBellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Short Interest UpdateApril 21, 2023 | wsj.comBellevue Life Sciences Acquisition Corp.April 18, 2023 | seekingalpha.comBLACW Bellevue Life Sciences Acquisition Corp. WT EXP 020928See More Headlines Receive BLAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:BLAC CUSIPN/A CIK1840425 Webwww.bellevuespac.com Phone425-635-7700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares5,620,000Free Float4,740,000Market Cap$60.47 million OptionableNot Optionable Beta-0.03 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Kuk Hyoun Hwang (Age 47)CEO & Director Mr. David Jin Yoo (Age 50)Chief Financial Officer Key CompetitorsCorner Growth Acquisition Corp. 2NASDAQ:TRONInception Growth AcquisitionNASDAQ:IGTANewbury Street AcquisitionNASDAQ:NBSTJVSPAC AcquisitionNASDAQ:JVSAHHG CapitalNASDAQ:HHGCView All CompetitorsInstitutional OwnershipK2 Principal Fund L.P.Bought 33,589 shares on 5/14/2024Ownership: 0.598%Wealthspring Capital LLCSold 32,684 shares on 4/18/2024Ownership: 0.606%View All Institutional Transactions BLAC Stock Analysis - Frequently Asked Questions How have BLAC shares performed in 2024? Bellevue Life Sciences Acquisition's stock was trading at $10.50 at the beginning of the year. Since then, BLAC stock has increased by 2.5% and is now trading at $10.76. View the best growth stocks for 2024 here. Who are Bellevue Life Sciences Acquisition's major shareholders? Bellevue Life Sciences Acquisition's stock is owned by a number of retail and institutional investors. Top institutional investors include Wealthspring Capital LLC (0.61%) and K2 Principal Fund L.P. (0.60%). How do I buy shares of Bellevue Life Sciences Acquisition? Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BLAC) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.